Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab

Shuntaro Ikegawa; Yusuke Meguri; Kentaro Mizuhara; Takuya Fukumi; Hiroki Kobayashi; Yuichi Sumii; Takumi Kondo; Yasuhisa Sando; Miki Iwamoto; Noboru Asada; Daisuke Ennishi; Hisakazu Nishimori; Keiko Fujii; Nobuharu Fujii; Yuka Fujisawa; Toshi Imai; Yoshinobu Maeda; Ken ichi Matsuoka

doi:10.1038/s41375-021-01167-8

Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab

Shuntaro Ikegawa, Yusuke Meguri, Kentaro Mizuhara, Takuya Fukumi, Hiroki Kobayashi, Yuichi Sumii, Takumi Kondo, Yasuhisa Sando, Miki Iwamoto, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Yuka Fujisawa, Toshi Imai, Yoshinobu Maeda, Ken ichi Matsuoka

Research output: Contribution to journal › Letter › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	929-931
Number of pages	3
Journal	Leukemia
Volume	35
Issue number	3
DOIs	https://doi.org/10.1038/s41375-021-01167-8
Publication status	Published - Mar 2021

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41375-021-01167-8

Cite this

Ikegawa, S., Meguri, Y., Mizuhara, K., Fukumi, T., Kobayashi, H., Sumii, Y., Kondo, T., Sando, Y., Iwamoto, M., Asada, N., Ennishi, D., Nishimori, H., Fujii, K., Fujii, N., Fujisawa, Y., Imai, T., Maeda, Y., & Matsuoka, K. I. (2021). Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab. Leukemia, 35(3), 929-931. https://doi.org/10.1038/s41375-021-01167-8

Ikegawa, S, Meguri, Y, Mizuhara, K, Fukumi, T, Kobayashi, H, Sumii, Y, Kondo, T, Sando, Y, Iwamoto, M, Asada, N , Ennishi, D , Nishimori, H , Fujii, K , Fujii, N, Fujisawa, Y, Imai, T, Maeda, Y & Matsuoka, KI 2021, 'Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab', Leukemia, vol. 35, no. 3, pp. 929-931. https://doi.org/10.1038/s41375-021-01167-8

@article{01b21f5088e446e9a37fbc7dc98aa128,

title = "Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab",

author = "Shuntaro Ikegawa and Yusuke Meguri and Kentaro Mizuhara and Takuya Fukumi and Hiroki Kobayashi and Yuichi Sumii and Takumi Kondo and Yasuhisa Sando and Miki Iwamoto and Noboru Asada and Daisuke Ennishi and Hisakazu Nishimori and Keiko Fujii and Nobuharu Fujii and Yuka Fujisawa and Toshi Imai and Yoshinobu Maeda and Matsuoka, {Ken ichi}",

note = "Funding Information: Acknowledgements The authors would like to thank Kyoko Maeda and Hiromi Nakashima for help with obtaining clinical samples. This work was supported by research funding from the Japan Society for the Promotion of Science KAKENHI (Grant No. 20K08753) to KM.",

year = "2021",

month = mar,

doi = "10.1038/s41375-021-01167-8",

language = "English",

volume = "35",

pages = "929--931",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab

AU - Ikegawa, Shuntaro

AU - Meguri, Yusuke

AU - Mizuhara, Kentaro

AU - Fukumi, Takuya

AU - Kobayashi, Hiroki

AU - Sumii, Yuichi

AU - Kondo, Takumi

AU - Sando, Yasuhisa

AU - Iwamoto, Miki

AU - Asada, Noboru

AU - Ennishi, Daisuke

AU - Nishimori, Hisakazu

AU - Fujii, Keiko

AU - Fujii, Nobuharu

AU - Fujisawa, Yuka

AU - Imai, Toshi

AU - Maeda, Yoshinobu

AU - Matsuoka, Ken ichi

N1 - Funding Information: Acknowledgements The authors would like to thank Kyoko Maeda and Hiromi Nakashima for help with obtaining clinical samples. This work was supported by research funding from the Japan Society for the Promotion of Science KAKENHI (Grant No. 20K08753) to KM.

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85101014267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101014267&partnerID=8YFLogxK

U2 - 10.1038/s41375-021-01167-8

DO - 10.1038/s41375-021-01167-8

M3 - Letter

C2 - 33597730

AN - SCOPUS:85101014267

SN - 0887-6924

VL - 35

SP - 929

EP - 931

JO - Leukemia

JF - Leukemia

IS - 3

ER -

Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this